Matralix Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Matralix General Information

Description

Developer of encapsulation systems designed to accelerate the delivery of novel products to market. The company's systems use minimal materials for the quick formulation of design and screening and are scalable from research and development to pilot to commercial scale, enabling formulation scientists to enhance their productivity and quality of the final product over conventional batch methods.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 71 Ayer Rajah Crescent
  • Number 07-05
  • Singapore, 139951
  • Singapore
Primary Industry
Machinery (B2B)
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 71 Ayer Rajah Crescent
  • Number 07-05
  • Singapore, 139951
  • Singapore

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Matralix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 18-Jul-2026 Completed Out of Business
3. Later Stage VC 01-Jun-2021 Completed Generating Revenue
2. Later Stage VC 15-Jul-2019 $2.41M $2.41M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Matralix’s complete valuation and funding history, request access »

Matralix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Matralix’s complete cap table history, request access »

Matralix Patents

Matralix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3953686-A2 Label-free detection of mycobacteria using surface enhanced raman spectroscopy Inactive 09-Apr-2019
EP-3953686-A4 Label-free detection of mycobacteria using surface enhanced raman spectroscopy Inactive 09-Apr-2019
US-20220162663-A1 Label-free detection of mycobacteria using surface enhanced raman spectroscopy Inactive 09-Apr-2019
WO-2020209796-A2 Label-free detection of mycobacteria using surface enhanced raman spectroscopy Inactive 09-Apr-2019
WO-2020209796-A3 Label-free detection of mycobacteria using surface enhanced raman spectroscopy Inactive 09-Apr-2019 C12Q1/02
To view Matralix’s complete patent history, request access »

Matralix FAQs

  • When was Matralix founded?

    Matralix was founded in 2013.

  • Where is Matralix headquartered?

    Matralix is headquartered in Singapore, Singapore.

  • What industry is Matralix in?

    Matralix’s primary industry is Machinery (B2B).

  • Is Matralix a private or public company?

    Matralix is a Private company.

  • What is Matralix’s current revenue?

    The current revenue for Matralix is .

  • How much funding has Matralix raised over time?

    Matralix has raised $2.41M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process